Advertisment
Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:65

Official publication of the Indian Society of Nephrology
  Search
 
 ~ Next article
 ~ Previous article 
 ~ Table of Contents
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (243 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   References

 Article Access Statistics
    Viewed1164    
    Printed68    
    Emailed0    
    PDF Downloaded82    
    Comments [Add]    

Recommend this journal

 


 
LETTER TO EDITOR
Year : 2009  |  Volume : 19  |  Issue : 4  |  Page : 175
 

Reply to 'kidney transplantation in a patient with HIV disease'


Department of Nephrology and Kidney Transplantation, Fortis Hospital, Noida, India

Date of Web Publication22-Jan-2010

Correspondence Address:
S B Bansal
B-22, Sector 62, Noida, UP-201 301
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20535260

Rights and PermissionsRights and Permissions



How to cite this article:
Bansal S B, Singhal M, Ahlawat R, Kher V. Reply to 'kidney transplantation in a patient with HIV disease'. Indian J Nephrol 2009;19:175

How to cite this URL:
Bansal S B, Singhal M, Ahlawat R, Kher V. Reply to 'kidney transplantation in a patient with HIV disease'. Indian J Nephrol [serial online] 2009 [cited 2019 Aug 21];19:175. Available from: http://www.indianjnephrol.org/text.asp?2009/19/4/175/59346


Sir,

I thank Dr. Gonzalez for replying. [1] I want to make following points in response:

  1. The goal of initial HAART in the naïve patient should be to devise a regimen that will achieve maximal durable viral suppression (<50 copies/mL) and be tolerated for an indefinite period of time. [2],[3]
  2. For ARV therapy-naïve patients, the initial HAART regimen should include a combination of two nucleoside reverse transcriptase inhibitors (NRTIs) plus either a ritonavir-boosted protease inhibitor (PI), or a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unfortunately, there is no clear data available at present on which to base distinction between these two approaches.[2],[3]
  3. The use of NNRTI-based regimen for initial therapy may preserve PIs for later use. [3] For NNRTI the preferred drug is efavirenz, but nevirapine can be used as an alternative drug in combination with two NRTIs. [3]
  4. We agree with you that clinicians should not use nevirapine as part of the initial regimen in women with CD4 counts >250 cells/mm 3 or men with CD4 counts >400 cells/mm 3 . However, it can be used in men and women with CD4 counts <400 and <250 cells/mm 3 , respectively. [3] As this patient was already on this regimen, when he came to us for transplant and was responding to treatment as evident by his CD4 cell count and HIV RNA levels. [4]
  5. The nevirapine as initial treatment is contraindicated only in cases of moderate to severe hepatic impairment (Child-Pugh score B or C). [3] This patient had normal hepatic function initially and later on he had mild increase in aminotransferase levels, which improved after reduction in dose of drug. [4]
  6. When nevirapine or efavirenz were used as initial treatment, no significant difference was noted in efficacy between these two drugs in combination with stavudine and lamivudine and toxicity was only slightly higher with nevirapine. [5]
  7. Lamivudine/stavudine/nevirapine is one of the prescribed regimens for treatment of HIV in African countries as approved by the World Health Organization. It is used as a first-line combination in eight African countries. This is also the most cost-effective initial drug regimen. [6]
  8. I agree with the author that measuring serum antiretroviral drug levels after transplant might help with drug dosing.


 
  References Top

1.Gonzalez-Granado LI. Kidney transplantation in a patient with HIV disease. Indian J Nephrol 2009;19:126.  Back to cited text no. 1    Medknow Journal  
2.WHO Library Cataloguing-in-Publication Data. Antiretroviral therapy for hiv infection in adults and adolescents: Recommendations for a public health approach. Available from http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf. [cited on 2009 Sep 30].  Back to cited text no. 2      
3.Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available from: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. [cited on 2008 Nov 3].  Back to cited text no. 3      
4.Bansal SM, Singhal M, Kher V. Kidney transplantation in a patient with HIV disease. Indian J Nephrol 2009;19:77-9.  Back to cited text no. 4    Medknow Journal  
5.Van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: A randomized open-label trial, the 2NN Study. Lancet 2004;363:1253-63.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Available from: http://www.who.int/hiv/amds/en/Standard_Treatment_Guidelines-Final.pdf. [cited in 2009].  Back to cited text no. 6      




 

Top
Print this article  Email this article
Previous article Next article

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07